AURIMOD is a commercial stage medical device company founded to disrupt global healthcare by patient-tailored electroceutical pain therapies. We develop products for the minimal-invasive electrical stimulation of the auricular branch of the vagus nerve. By this autonomic stimulation we harness the bodies’ own mechanisms to fight the disease sustainably with a clinically proven effect.
R&D:We focus our research on the development of smart non-pharmacological solutions for pain patients including closed-loop therapy management systems.